Development and License Agreement (Insulin)Development and License Agreement • December 21st, 2010 • Emisphere Technologies Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 21st, 2010 Company Industry JurisdictionTHIS DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”) is entered into as of 20 December, 2010 (the “Effective Date”) by and between and EMISPHERE TECHNOLOGIES, INC., a Delaware corporation having an address at 240 Cedar Knolls Road, Cedar Knolls, NJ 07927, USA (“Emisphere”) and NOVO NORDISK AS, a Danish corporation having an address at Novo Allé, 2880 Bagsvaerd, Denmark (“Novo Nordisk”).